Fig. 2 | Hypertension Research

Fig. 2

From: Efficacy and safety of esaxerenone with and without sodium–glucose cotransporter-2 inhibitor use in hypertensive patients with type 2 diabetes mellitus: a pooled analysis of five clinical studies

Fig. 2

Achievement rates (morning home BP) for target BP levels (SBP/DBP < 135/85 mmHg and SBP/DBP < 125/75 mmHg) at Week 12 in the overall population and in the SGLT2i and non-SGLT2i subgroups (full analysis set). BP blood pressure, DBP diastolic BP, SBP systolic BP, SGLT2i sodium–glucose cotransporter-2 inhibitor

Back to article page